secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001161697-23-000280
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical Q1 revenue $7.4M (+18% YoY); reaffirms FY2023 guidance
-------------------------------------------------------------------

- Q1 net revenue $7.4M, up 18% YoY; net loss $2.4M ($0.05 diluted) vs $2.5M loss prior year.
- U.S. Core revenue $5.7M (+15%), International Core $1.1M (+23%), Novel Therapies $0.6M (+62%).
- Gross margin 56.1% (down from 58%), but reaffirms FY margin 58-60% and exit at 60-62%.
- Reaffirms FY2023 revenue guidance $32.5-33.5M (17-20% growth); cash >$10M year-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169723000280/0001161697-23-000280-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169723000280/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-23-000280

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer